Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (121-130 of 311) with videos related to

Pageof 32
Sort By:
Arthritis Research & Therapy|March 2, 2006
No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndromeJacques-Eric Gottenberg, Jérémie Sellam, Marc Ittah, et al.
Arthritis Research & Therapy|October 17, 2009
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activityJérémie Sellam, Valérie Proulle, Astrid Jüngel, et al.
Journal of Autoimmunity|January 14, 2014
Outcome measures for primary Sjögren's syndrome: a comprehensive reviewRaphaèle Seror, Elke Theander, Hendrika Bootsma, et al.
The Journal of Rheumatology|April 17, 2012
Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: data from the French AIR registryLaure Thomas, Florence Canoui-Poitrine, Jacques-Eric Gottenberg, et al.
Journal of Clinical Medicine|February 25, 2022
Effect of Transcutaneous Vagus Nerve Stimulation in Erosive Hand Osteoarthritis: Results from a Pilot TrialAlice Courties, Camille Deprouw, Emmanuel Maheu, et al.
Journal of Autoimmunity|February 28, 2012
Outcome measures for primary Sjögren's syndromeRaphaèle Seror, Hendrika Bootsma, Simon J Bowman, et al.
Rheumatology (Oxford, England)|October 26, 2017
Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry dataJean-Hugues Salmon, Jeanne-Marie Perotin, Jacques Morel, et al.
Joint Bone Spine|December 17, 2008
Rituximab (MabThera) therapy and safety management. Clinical tool guideThao Pham, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Clinical Rheumatology|March 27, 2020
Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFαMinh Vu Chuong Nguyen, Anaïs Courtier, Annie Adrait, et al.
Cell Death & Disease|February 27, 2019
The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle sheddingSara Mouasni, Virginie Gonzalez, Alain Schmitt, et al.
Pageof 32

Showing results (121-130 of 311) with videos related to

Sort By:
Pageof 32
Arthritis Research & Therapy|March 2, 2006
No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndromeJacques-Eric Gottenberg, Jérémie Sellam, Marc Ittah, et al.
Arthritis Research & Therapy|October 17, 2009
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activityJérémie Sellam, Valérie Proulle, Astrid Jüngel, et al.
Journal of Autoimmunity|January 14, 2014
Outcome measures for primary Sjögren's syndrome: a comprehensive reviewRaphaèle Seror, Elke Theander, Hendrika Bootsma, et al.
The Journal of Rheumatology|April 17, 2012
Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: data from the French AIR registryLaure Thomas, Florence Canoui-Poitrine, Jacques-Eric Gottenberg, et al.
Journal of Clinical Medicine|February 25, 2022
Effect of Transcutaneous Vagus Nerve Stimulation in Erosive Hand Osteoarthritis: Results from a Pilot TrialAlice Courties, Camille Deprouw, Emmanuel Maheu, et al.
Journal of Autoimmunity|February 28, 2012
Outcome measures for primary Sjögren's syndromeRaphaèle Seror, Hendrika Bootsma, Simon J Bowman, et al.
Rheumatology (Oxford, England)|October 26, 2017
Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry dataJean-Hugues Salmon, Jeanne-Marie Perotin, Jacques Morel, et al.
Joint Bone Spine|December 17, 2008
Rituximab (MabThera) therapy and safety management. Clinical tool guideThao Pham, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Clinical Rheumatology|March 27, 2020
Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFαMinh Vu Chuong Nguyen, Anaïs Courtier, Annie Adrait, et al.
Cell Death & Disease|February 27, 2019
The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle sheddingSara Mouasni, Virginie Gonzalez, Alain Schmitt, et al.
Pageof 32